The Lens: Difference between revisions
Provision of reliable, secondary sources and references to third-party publications, in addition to statistical updates. |
Bibliographic referencing |
||
| Line 6: | Line 6: | ||
Searches of the Patent Lens can be undertaken using numerous variables, including full-text, title, abstract, inventor, applicant/assignee, publication number and filing number. A user is also able to search for lapsed, abandoned, or expired US patents via the [[INPADOC]] patent status and family information service. Patent families may be visualized using graphical trees as pdfs. |
Searches of the Patent Lens can be undertaken using numerous variables, including full-text, title, abstract, inventor, applicant/assignee, publication number and filing number. A user is also able to search for lapsed, abandoned, or expired US patents via the [[INPADOC]] patent status and family information service. Patent families may be visualized using graphical trees as pdfs. |
||
The Patent Lens currently links to regulatory data in the form of the United States [[Food and Drug Administration]] (FDA) ''Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations''.<ref>http://www.accessdata.fda.gov/scripts/cder/ob/default.cfm</ref> Biological sequence data is integrated via links to [[National Center for Biotechnology Information]] (NCBI) [[GenBank]] and the Patent Lens' own gene sequences. The Patent Lens Sequence Project,<ref>http://www.patentlens.net/daisy/patentlens/landscapes-tools/sequences.html</ref> commenced in June 2006, provides the only public facility to enable users to explore over 80 million [[DNA]] and [[protein sequences]] disclosed in patents.<ref>http://www.patentlens.net/daisy/cambia/3102/version/default/part/AttachmentData/data/ICPMB%20extended%20abstract.pdf</ref> |
The Patent Lens currently links to regulatory data in the form of the United States [[Food and Drug Administration]] (FDA) ''Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations''.<ref>{{cite web | url = http://www.accessdata.fda.gov/scripts/cder/ob/default.cfm | title = United States Food and Drug Administration ''Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations'' | accessdate = 2010-01-04}}</ref> Biological sequence data is integrated via links to [[National Center for Biotechnology Information]] (NCBI) [[GenBank]] and the Patent Lens' own gene sequences. The Patent Lens Sequence Project,<ref>{{cite web | url = http://www.patentlens.net/daisy/patentlens/landscapes-tools/sequences.html | title = Cambia’s Sequence Project | accessdate = 2010-01-04}}</ref> commenced in June 2006, provides the only public facility to enable users to explore over 80 million [[DNA]] and [[protein sequences]] disclosed in patents.<ref>{{cite journal | url = http://www.patentlens.net/daisy/cambia/3102/version/default/part/AttachmentData/data/ICPMB%20extended%20abstract.pdf | title = Constructive approaches to Intellectual Property Complexity in Today’s Agricultural Technology World | year = 2007 | author = Connett Porceddu, MB, Bacon, N, Ashton, D, Baillie, B, dos Remedios, N, Wei, Y, Jefferson, RA | journal = Plant Molecular Breeding | volume = 5 | issue = 2 | pages = 294–295}}</ref> |
||
Patent tutorials<ref>http://www.patentlens.net/daisy/patentlens/ip.html</ref> are available on the site covering [[patent claims]], [[freedom to operate]], [[inventor (patent)|patent inventorship]], and [[continuing patent application]]s. [[Plant breeders' rights]] (PBR), also known as plant variety rights (PVR), are also addressed. |
Patent tutorials<ref>{{cite web | url = http://www.patentlens.net/daisy/patentlens/ip.html | title = Patent Tutorials and FAQs | accessdate = 2010-01-04}}</ref> are available on the site covering [[patent claims]], [[freedom to operate]], [[inventor (patent)|patent inventorship]], and [[continuing patent application]]s. [[Plant breeders' rights]] (PBR), also known as plant variety rights (PVR), are also addressed. |
||
==Native Language Support== |
==Native Language Support== |
||
| Line 14: | Line 14: | ||
==Technology Landscapes== |
==Technology Landscapes== |
||
In addition to the patent search engine, the Patent Lens also hosts a number of “technology landscapes”.<ref>http://www.patentlens.net/daisy/patentlens/landscapes-tools |
In addition to the patent search engine, the Patent Lens also hosts a number of “technology landscapes”.<ref>{{cite web | url = http://www.patentlens.net/daisy/patentlens/landscapes-tools| title = Patent Lens Technology Landscapes | accessdate = 2010-01-04}}</ref> These landscapes serve as interpretation maps that analyze volumes of specialized patent, scientific, technical and business data around particular topics into a more navigable form. |
||
In the field of health and medicine, landscapes have been created for [[human genome]] patenting, the [[influenza]] genome, the human [[Telomerase]] gene, molecular markers outside gene sequences, and [[adjuvants]]. For agriculture and the environment, landscapes exist to describe the [[Agrobacterium]]-mediated transformation of plants, promoters used to regulate gene expression, antibiotic resistance genes and their uses in plant genetic transformation, resistance to [[Phosphinothricin]], positive selection, [[bioindicators]]/ambiosensors, and the rice genome. |
In the field of health and medicine, landscapes have been created for [[human genome]] patenting, the [[influenza]] genome, the human [[Telomerase]] gene, molecular markers outside gene sequences, and [[adjuvants]]. For agriculture and the environment, landscapes exist to describe the [[Agrobacterium]]-mediated transformation of plants, promoters used to regulate gene expression, antibiotic resistance genes and their uses in plant genetic transformation, resistance to [[Phosphinothricin]], positive selection, [[bioindicators]]/ambiosensors, and the rice genome. |
||
| Line 21: | Line 21: | ||
==Endorsement== |
==Endorsement== |
||
The landscaping activities of the Patent Lens have been endorsed by Dr. Francis Gurry, Director General of the [[World Intellectual Property Organization]] (WIPO) in March, 2009, in 'view of the shared objective of making patent information systems more comprehensive and accessible, and turning raw patent data into useful information resources so as to strengthen the empirical basis of international policy processes.'<ref>http://www.openinnovation.org/daisy/ioi/4411/version/default/part/AttachmentData/data/Endorsement%20from%20Francis%20Gurry.pdf</ref> |
The landscaping activities of the Patent Lens have been endorsed by Dr. Francis Gurry, Director General of the [[World Intellectual Property Organization]] (WIPO) in March, 2009, in 'view of the shared objective of making patent information systems more comprehensive and accessible, and turning raw patent data into useful information resources so as to strengthen the empirical basis of international policy processes.'<ref>{{cite web | url = http://www.openinnovation.org/daisy/ioi/4411/version/default/part/AttachmentData/data/Endorsement%20from%20Francis%20Gurry.pdf | title = Patent Lens Letter of Endorsement from Dr. Francis Gurry, Director General, World Intellectual Property Organization (WIPO) | accessdate = 2010-01-04}}</ref> |
||
''Nature Biotechnology'' has called the Patent Lens 'a giant leap in the right direction' for providing researchers, [[technology transfer|technology transfer offices]] and company executives a facile means of establishing the novelty of their offerings and the nature of their competitors' inventions. <ref> |
''Nature Biotechnology'' has called the Patent Lens 'a giant leap in the right direction' for providing researchers, [[technology transfer|technology transfer offices]] and company executives a facile means of establishing the novelty of their offerings and the nature of their competitors' inventions. <ref>{{cite journal | doi = 10.1038/nbt0506-474a | title = Patently Transparent | year = 2006 | journal = Nature Biotechnology | volume = 24 | issue = 5 | pages = 474}}</ref> |
||
==See also== |
==See also== |
||
Revision as of 07:15, 4 January 2010
 | The topic of this article may not meet Wikipedia's general notability guideline. (January 2008) |
 |
The Patent Lens is an online patent search facility and knowledge resource, provided by Cambia, an independent, international non-profit organization dedicated to democratizing innovation. Launched in 2000, the Patent Lens allows free searching of almost 10 million full-text patent documents, including United States patents and applications, Australian patents and applications, European patents and Patent Cooperation Treaty (PCT) applications. The Patent Lens is distinguished as being the only not-for-profit facility of its kind, with international coverage and links to non-patent literature and tutorials.
Searches of the Patent Lens can be undertaken using numerous variables, including full-text, title, abstract, inventor, applicant/assignee, publication number and filing number. A user is also able to search for lapsed, abandoned, or expired US patents via the INPADOC patent status and family information service. Patent families may be visualized using graphical trees as pdfs.
The Patent Lens currently links to regulatory data in the form of the United States Food and Drug Administration (FDA) Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations.[1] Biological sequence data is integrated via links to National Center for Biotechnology Information (NCBI) GenBank and the Patent Lens' own gene sequences. The Patent Lens Sequence Project,[2] commenced in June 2006, provides the only public facility to enable users to explore over 80 million DNA and protein sequences disclosed in patents.[3]
Patent tutorials[4] are available on the site covering patent claims, freedom to operate, patent inventorship, and continuing patent applications. Plant breeders' rights (PBR), also known as plant variety rights (PVR), are also addressed.
Native Language Support
The patent search interface is available in Chinese, English and French, with the full text of European Patent Office (EPO) patents being searchable in English, French and German. PCT applications are searchable in Chinese, English, French, German, Japanese, Korean, Russian and Spanish.
Technology Landscapes
In addition to the patent search engine, the Patent Lens also hosts a number of “technology landscapes”.[5] These landscapes serve as interpretation maps that analyze volumes of specialized patent, scientific, technical and business data around particular topics into a more navigable form.
In the field of health and medicine, landscapes have been created for human genome patenting, the influenza genome, the human Telomerase gene, molecular markers outside gene sequences, and adjuvants. For agriculture and the environment, landscapes exist to describe the Agrobacterium-mediated transformation of plants, promoters used to regulate gene expression, antibiotic resistance genes and their uses in plant genetic transformation, resistance to Phosphinothricin, positive selection, bioindicators/ambiosensors, and the rice genome.
From 2000-2004, the Rockefeller Foundation backed development of the initial technology landscapes. In 2005, the Patent Lens made the landscapes fully navigable, interactive and updatable by users.
Endorsement
The landscaping activities of the Patent Lens have been endorsed by Dr. Francis Gurry, Director General of the World Intellectual Property Organization (WIPO) in March, 2009, in 'view of the shared objective of making patent information systems more comprehensive and accessible, and turning raw patent data into useful information resources so as to strengthen the empirical basis of international policy processes.'[6]
Nature Biotechnology has called the Patent Lens 'a giant leap in the right direction' for providing researchers, technology transfer offices and company executives a facile means of establishing the novelty of their offerings and the nature of their competitors' inventions. [7]
See also
References
- ^ "United States Food and Drug Administration Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations". Retrieved 2010-01-04.
- ^ "Cambia's Sequence Project". Retrieved 2010-01-04.
- ^ Connett Porceddu, MB, Bacon, N, Ashton, D, Baillie, B, dos Remedios, N, Wei, Y, Jefferson, RA (2007). "Constructive approaches to Intellectual Property Complexity in Today's Agricultural Technology World" (PDF). Plant Molecular Breeding. 5 (2): 294–295.
{{cite journal}}: CS1 maint: multiple names: authors list (link) - ^ "Patent Tutorials and FAQs". Retrieved 2010-01-04.
- ^ "Patent Lens Technology Landscapes". Retrieved 2010-01-04.
- ^ "Patent Lens Letter of Endorsement from Dr. Francis Gurry, Director General, World Intellectual Property Organization (WIPO)" (PDF). Retrieved 2010-01-04.
- ^ "Patently Transparent". Nature Biotechnology. 24 (5): 474. 2006. doi:10.1038/nbt0506-474a.